A binding-enhanced but enzymatic activity-eliminated human ACE2 efficiently neutralizes SARS-CoV-2 variants
Anqi Zheng(Peking University), Pu Han(Chinese Academy of Sciences), Renyi Ma(Chinese Academy of Sciences), Qihui Wang(Shanxi Agricultural University), Baoying Huang(Chinese Center For Disease Control and Prevention), Pengcheng Han(Zhongda Hospital Southeast University), Lili Wu(Chinese Academy of Sciences), Chengpeng Qiao(Chinese Academy of Sciences), Wenjie Tan(Chinese Academy of Sciences), George F. Gao(Chinese Academy of Sciences), Pu Han(Chinese Center For Disease Control and Prevention)
Cited by 15
Related Papers
A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
|Trends in Microbiology|2016|3.1k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k